Oncosil Medical Ltd has released a press release.
Appendix 4C & Quarterly Update
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Story so far
Earlier from OncoSil Medical
- Response to Price Query
- Oncosil submits Clinical Study Report to Notified Body
- Clinical Programme Update
- Oncosil Medical Share Purchase Plan
- Successful Completion of Capital Raising
Later from OncoSil Medical
- Preliminary Final Report
- IQVIA appointed EU Market Access and Reimbursement Advisor
- R&D Refund - 2018 Financial Year
- PanCo Study Interim Analysis
- CE Marking Update
Follow OncoSil Medical into a list and get an email when it puts out news.
Follow OncoSil Medical